Impact of risk factors on early cancer evolution

CE Weeden, W Hill, EL Lim, E Grönroos, C Swanton - Cell, 2023‏ - cell.com
Recent identification of oncogenic cells within healthy tissues and the prevalence of indolent
cancers found incidentally at autopsies reveal a greater complexity in tumor initiation than …

Advances in diagnosis and management of cancer of the esophagus

N Deboever, CM Jones, K Yamashita, JA Ajani… - Bmj, 2024‏ - bmj.com
Esophageal cancer is the seventh most common malignancy worldwide, with over 470 000
new cases diagnosed each year. Two distinct histological subtypes predominate, and …

Extrachromosomal DNA in the cancerous transformation of Barrett's oesophagus

J Luebeck, AWT Ng, PC Galipeau, X Li, CA Sanchez… - Nature, 2023‏ - nature.com
Oncogene amplification on extrachromosomal DNA (ecDNA) drives the evolution of tumours
and their resistance to treatment, and is associated with poor outcomes for patients with …

Molecular phenoty** reveals the identity of Barrett's esophagus and its malignant transition

K Nowicki-Osuch, L Zhuang, S Jammula, CW Bleaney… - Science, 2021‏ - science.org
The origin of human metaplastic states and their propensity for cancer is poorly understood.
Barrett's esophagus is a common metaplastic condition that increases the risk for …

[HTML][HTML] Distinct classes of complex structural variation uncovered across thousands of cancer genome graphs

K Hadi, X Yao, JM Behr, A Deshpande… - Cell, 2020‏ - cell.com
Cancer genomes often harbor hundreds of somatic DNA rearrangement junctions, many of
which cannot be easily classified into simple (eg, deletion) or complex (eg, chromothripsis) …

Dissecting esophageal squamous-cell carcinoma ecosystem by single-cell transcriptomic analysis

X Zhang, L Peng, Y Luo, S Zhang, Y Pu, Y Chen… - Nature …, 2021‏ - nature.com
Esophageal squamous-cell carcinoma (ESCC), one of the most prevalent and lethal
malignant disease, has a complex but unknown tumor ecosystem. Here, we investigate the …

[HTML][HTML] A deep learning framework for predicting response to therapy in cancer

T Sakellaropoulos, K Vougas, S Narang, F Koinis… - Cell reports, 2019‏ - cell.com
A major challenge in cancer treatment is predicting clinical response to anti-cancer drugs on
a personalized basis. Using a pharmacogenomics database of 1,001 cancer cell lines, we …

SLNL: A novel method for gene selection and phenotype classification

HH Huang, NQ Wu, Y Liang… - International Journal of …, 2022‏ - Wiley Online Library
One of the central tasks of genome research is to predict phenotypes and discover some
important gene biomarkers. However, there are three main problems in analyzing genomics …

Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma

Y Cui, H Chen, R **, H Cui, Y Zhao, E Xu, T Yan, X Lu… - Cell research, 2020‏ - nature.com
Esophageal squamous cell carcinoma (ESCC) is a poor-prognosis cancer type with limited
understanding of its molecular etiology. Using 508 ESCC genomes, we identified five novel …

Single-cell RNA sequencing unifies developmental programs of esophageal and gastric intestinal metaplasia

K Nowicki-Osuch, L Zhuang, TS Cheung… - Cancer …, 2023‏ - aacrjournals.org
Intestinal metaplasia in the esophagus (Barrett's esophagus IM, or BE-IM) and stomach
(GIM) are considered precursors for esophageal and gastric adenocarcinoma, respectively …